Probiotics during the first 7 years of life: a cumulative risk reduction of eczema in a randomized, placebo-controlled trial.

PubWeight™: 1.48‹?› | Rank: Top 4%

🔗 View Article (PMID 17289135)

Published in J Allergy Clin Immunol on February 07, 2007

Authors

Marko Kalliomäki, Seppo Salminen, Tuija Poussa, Erika Isolauri

Associated clinical trials:

Safety of VSL#3 in Adult Asthmatics | NCT00852124

Clinical Study of Novel Probiotic Microbial Composite™ to Treat Undernourished Young Children | NCT03150927

Articles citing this

The 'hygiene hypothesis' for autoimmune and allergic diseases: an update. Clin Exp Immunol (2010) 3.17

Psychoneuroimmunology meets neuropsychopharmacology: translational implications of the impact of inflammation on behavior. Neuropsychopharmacology (2011) 2.31

Gut microbiota, probiotics, and vitamin D: interrelated exposures influencing allergy, asthma, and obesity? J Allergy Clin Immunol (2011) 2.01

Probiotics and immunity. J Gastroenterol (2009) 1.79

Probiotic supplementation during pregnancy or infancy for the prevention of asthma and wheeze: systematic review and meta-analysis. BMJ (2013) 1.67

Microbial contact during pregnancy, intestinal colonization and human disease. Nat Rev Gastroenterol Hepatol (2012) 1.62

Toll-like receptor 2 and nucleotide-binding oligomerization domain-2 play divergent roles in the recognition of gut-derived lactobacilli and bifidobacteria in dendritic cells. Immunology (2008) 1.58

Safety assessment of probiotics for human use. Gut Microbes (2010) 1.44

Maternal intestinal flora and wheeze in early childhood. Clin Exp Allergy (2012) 1.43

Retracted Preventative and therapeutic probiotic use in allergic skin conditions: experimental and clinical findings. Biomed Res Int (2013) 1.39

Maternal allergic disease history affects childhood allergy development through impairment of neonatal regulatory T-cells. Respir Res (2016) 1.38

Lactobacillus fermentum ME-3 - an antimicrobial and antioxidative probiotic. Microb Ecol Health Dis (2009) 1.38

Microbial ecology and host-microbiota interactions during early life stages. Gut Microbes (2012) 1.12

Early colonization with a group of Lactobacilli decreases the risk for allergy at five years of age despite allergic heredity. PLoS One (2011) 1.12

World Allergy Organization-McMaster University Guidelines for Allergic Disease Prevention (GLAD-P): Probiotics. World Allergy Organ J (2015) 1.07

The Effects of Lactobacillus rhamnosus on the Prevention of Asthma in a Murine Model. Allergy Asthma Immunol Res (2010) 1.07

Specific probiotics alleviate allergic rhinitis during the birch pollen season. World J Gastroenterol (2009) 0.99

The role of probiotics and prebiotics in inducing gut immunity. Front Immunol (2013) 0.99

Pathways to managing atopic dermatitis: consensus from the experts. J Clin Aesthet Dermatol (2013) 0.98

Diversity of the gut microbiota and eczema in early life. Clin Mol Allergy (2008) 0.97

Probiotic therapy as a novel approach for allergic disease. Front Pharmacol (2012) 0.95

Towards a better understanding of Lactobacillus rhamnosus GG--host interactions. Microb Cell Fact (2014) 0.93

Cost-effectiveness model for a specific mixture of prebiotics in The Netherlands. Eur J Health Econ (2010) 0.93

Cytokine profile and induction of T helper type 17 and regulatory T cells by human peripheral mononuclear cells after microbial exposure. Clin Exp Immunol (2012) 0.88

Effects of Bifidobacterium animalis administered during lactation on allergic and autoimmune responses in rodents. Clin Exp Immunol (2008) 0.87

Lactobacillus rhamnosus HN001 attenuates allergy development in a pig model. PLoS One (2011) 0.87

Piliation of Lactobacillus rhamnosus GG promotes adhesion, phagocytosis, and cytokine modulation in macrophages. Appl Environ Microbiol (2015) 0.86

Cow's milk allergy: from allergens to new forms of diagnosis, therapy and prevention. Methods (2013) 0.86

Probiotics and food allergy. Ital J Pediatr (2013) 0.85

Lipoteichoic acid is an important microbe-associated molecular pattern of Lactobacillus rhamnosus GG. Microb Cell Fact (2012) 0.85

99th Dahlem conference on infection, inflammation and chronic inflammatory disorders: neonatal immune function and vaccine responses in children born in low-income versus high-income countries. Clin Exp Immunol (2010) 0.85

Effects of diet on gut microbiota profile and the implications for health and disease. Biosci Microbiota Food Health (2013) 0.85

Early-life gut bacteria associate with IL-4-, IL-10- and IFN-γ production at two years of age. PLoS One (2012) 0.84

Perinatal probiotic supplementation in the prevention of allergy related disease: 6 year follow up of a randomised controlled trial. BMC Dermatol (2015) 0.83

The overarching influence of the gut microbiome on end-organ function: the role of live probiotic cultures. Pharmaceuticals (Basel) (2014) 0.83

Growth phase-associated changes in the proteome and transcriptome of Lactobacillus rhamnosus GG in industrial-type whey medium. Microb Biotechnol (2011) 0.82

Extracellular vesicles modulate host-microbe responses by altering TLR2 activity and phagocytosis. PLoS One (2014) 0.81

Role of dendritic cells: a step forward for the hygiene hypothesis. Cell Mol Immunol (2010) 0.80

A review of the pharmacobiotic regulation of gastrointestinal inflammation by probiotics, commensal bacteria and prebiotics. Inflammopharmacology (2012) 0.80

Identification and characterisation of an iron-responsive candidate probiotic. PLoS One (2011) 0.80

Neonatal colonization of mice with LGG promotes intestinal development and decreases susceptibility to colitis in adulthood. Mucosal Immunol (2016) 0.80

Probiotics and atopic dermatitis in children. Pharmaceuticals (Basel) (2012) 0.79

Extensively hydrolysed casein formula supplemented with Lactobacillus rhamnosus GG maintains hypoallergenic status: randomised double-blind, placebo-controlled crossover trial. BMJ Open (2012) 0.79

The role of innate immune signaling in the pathogenesis of atopic dermatitis and consequences for treatments. Semin Immunopathol (2015) 0.79

Probiotic lactic acid bacteria and their potential in the prevention and treatment of allergic diseases. Cent Eur J Immunol (2014) 0.78

The role of probiotics in allergic diseases. Allergy Asthma Clin Immunol (2009) 0.78

Allergic diseases among children: nutritional prevention and intervention. Ther Clin Risk Manag (2016) 0.78

Probiotics in the management of lung diseases. Mediators Inflamm (2013) 0.77

Probiotics for photoprotection. Dermatoendocrinol (2009) 0.76

Probiotics in the treatment and prevention of allergy in children. World Allergy Organ J (2009) 0.76

Long-term safety assessment in children who received hydrolyzed protein formulas with Lactobacillus rhamnosus GG: a 5-year follow-up. Eur J Pediatr (2016) 0.75

The Maternal Diet, Gut Bacteria, and Bacterial Metabolites during Pregnancy Influence Offspring Asthma. Front Immunol (2017) 0.75

Probiotics for Prevention of Atopy and Food Hypersensitivity in Early Childhood: A PRISMA-Compliant Systematic Review and Meta-Analysis of Randomized Controlled Trials. Medicine (Baltimore) (2016) 0.75

Probiotics in the treatment and prevention of allergies in children. Biosci Microflora (2011) 0.75

Intestinal microbiota and health in childhood. Biosci Microflora (2011) 0.75

Early Probiotic Supplementation for Eczema and Asthma Prevention: A Randomized Controlled Trial. Pediatrics (2017) 0.75

The possible mechanisms of the human microbiome in allergic diseases. Eur Arch Otorhinolaryngol (2016) 0.75

Articles by these authors

Host remodeling of the gut microbiome and metabolic changes during pregnancy. Cell (2012) 4.86

The human milk microbiome changes over lactation and is shaped by maternal weight and mode of delivery. Am J Clin Nutr (2012) 3.51

Early differences in fecal microbiota composition in children may predict overweight. Am J Clin Nutr (2008) 3.25

Probiotics: an overview of beneficial effects. Antonie Van Leeuwenhoek (2002) 3.09

Probiotics and prevention of atopic disease: 4-year follow-up of a randomised placebo-controlled trial. Lancet (2003) 2.92

Distinct composition of gut microbiota during pregnancy in overweight and normal-weight women. Am J Clin Nutr (2008) 2.48

Maternal probiotic supplementation during pregnancy and breast-feeding reduces the risk of eczema in the infant. J Allergy Clin Immunol (2012) 2.28

Guidelines for the diagnosis and management of cow's milk protein allergy in infants. Arch Dis Child (2007) 2.19

The Mucin degrader Akkermansia muciniphila is an abundant resident of the human intestinal tract. Appl Environ Microbiol (2007) 2.09

Mode of delivery and asthma -- is there a connection? Pediatr Res (2002) 1.99

Probiotics and dietary counselling contribute to glucose regulation during and after pregnancy: a randomised controlled trial. Br J Nutr (2008) 1.91

Lactobacillus bacteremia, clinical significance, and patient outcome, with special focus on probiotic L. rhamnosus GG. Clin Infect Dis (2003) 1.84

Probiotics prevent IgE-associated allergy until age 5 years in cesarean-delivered children but not in the total cohort. J Allergy Clin Immunol (2009) 1.80

Recommendations for probiotic use--2008. J Clin Gastroenterol (2008) 1.76

Long-term safety and impact on infection rates of postnatal probiotic and prebiotic (synbiotic) treatment: randomized, double-blind, placebo-controlled trial. Pediatrics (2008) 1.74

Intestinal integrity and Akkermansia muciniphila, a mucin-degrading member of the intestinal microbiota present in infants, adults, and the elderly. Appl Environ Microbiol (2007) 1.73

Breast milk: a source of bifidobacteria for infant gut development and maturation? Neonatology (2007) 1.72

Mucosal adhesion properties of the probiotic Lactobacillus rhamnosus GG SpaCBA and SpaFED pilin subunits. Appl Environ Microbiol (2010) 1.71

Mode of delivery - effects on gut microbiota and humoral immunity. Neonatology (2007) 1.69

Probiotics and prebiotic galacto-oligosaccharides in the prevention of allergic diseases: a randomized, double-blind, placebo-controlled trial. J Allergy Clin Immunol (2006) 1.66

Monitoring immune modulation by nutrition in the general population: identifying and substantiating effects on human health. Br J Nutr (2013) 1.64

Microbial contact during pregnancy, intestinal colonization and human disease. Nat Rev Gastroenterol Hepatol (2012) 1.62

New real-time quantitative PCR procedure for quantification of bifidobacteria in human fecal samples. Appl Environ Microbiol (2004) 1.51

Role of intestinal flora in the development of allergy. Curr Opin Allergy Clin Immunol (2003) 1.50

Effects of early prebiotic and probiotic supplementation on development of gut microbiota and fussing and crying in preterm infants: a randomized, double-blind, placebo-controlled trial. J Pediatr (2013) 1.50

Colonic methane production modifies gastrointestinal toxicity associated with adjuvant 5-fluorouracil chemotherapy for colorectal cancer. J Clin Gastroenterol (2013) 1.46

A fermented milk high in bioactive peptides has a blood pressure-lowering effect in hypertensive subjects. Am J Clin Nutr (2003) 1.45

Inflammation markers and malnutrition as risk factors for infections and impaired health-related quality of life among older nursing home residents. J Am Med Dir Assoc (2009) 1.44

Probiotic intervention in neonates--will permanent colonization ensue? J Pediatr Gastroenterol Nutr (2006) 1.44

Transmission of high-risk human papillomavirus (HPV) between parents and infant: a prospective study of HPV in families in Finland. J Clin Microbiol (2005) 1.44

PASSCLAIM--gut health and immunity. Eur J Nutr (2004) 1.43

Effect of probiotics and breastfeeding on the bifidobacterium and lactobacillus/enterococcus microbiota and humoral immune responses. J Pediatr (2005) 1.41

Probiotics during pregnancy and breast-feeding might confer immunomodulatory protection against atopic disease in the infant. J Allergy Clin Immunol (2002) 1.36

Effect of maternal consumption of lactobacillus GG on transfer and establishment of fecal bifidobacterial microbiota in neonates. J Pediatr Gastroenterol Nutr (2006) 1.35

Exopolysaccharides produced by probiotic strains modify the adhesion of probiotics and enteropathogens to human intestinal mucus. J Food Prot (2006) 1.34

Effect of mother's weight on infant's microbiota acquisition, composition, and activity during early infancy: a prospective follow-up study initiated in early pregnancy. Am J Clin Nutr (2010) 1.29

Impact of maternal probiotic-supplemented dietary counselling on pregnancy outcome and prenatal and postnatal growth: a double-blind, placebo-controlled study. Br J Nutr (2010) 1.29

Displacement of bacterial pathogens from mucus and Caco-2 cell surface by lactobacilli. J Med Microbiol (2003) 1.27

Should yoghurt cultures be considered probiotic? Br J Nutr (2005) 1.27

Similar bifidogenic effects of prebiotic-supplemented partially hydrolyzed infant formula and breastfeeding on infant gut microbiota. FEMS Immunol Med Microbiol (2005) 1.27

The hygiene hypothesis of atopic disease--an extended version. J Pediatr Gastroenterol Nutr (2004) 1.26

Rectal bleeding in infancy: clinical, allergological, and microbiological examination. Pediatrics (2006) 1.25

Initial dietary and microbiological environments deviate in normal-weight compared to overweight children at 10 years of age. J Pediatr Gastroenterol Nutr (2011) 1.24

The impact of probiotic on gut health. Curr Drug Metab (2009) 1.21

Staphylococcus aureus adheres to human intestinal mucus but can be displaced by certain lactic acid bacteria. Microbiology (2006) 1.21

New therapeutic strategy for combating the increasing burden of allergic disease: Probiotics-A Nutrition, Allergy, Mucosal Immunology and Intestinal Microbiota (NAMI) Research Group report. J Allergy Clin Immunol (2005) 1.19

Specific probiotics in reducing the risk of acute infections in infancy--a randomised, double-blind, placebo-controlled study. Br J Nutr (2008) 1.19

Health claims in Europe: probiotics and prebiotics as case examples. Annu Rev Food Sci Technol (2012) 1.19

Comparative genomic and functional analysis of Lactobacillus casei and Lactobacillus rhamnosus strains marketed as probiotics. Appl Environ Microbiol (2013) 1.18

Lactobacillus helveticus fermented milk lowers blood pressure in hypertensive subjects in 24-h ambulatory blood pressure measurement. Am J Hypertens (2005) 1.17

Effect of probiotics on constipation, fecal azoreductase activity and fecal mucin content in the elderly. Ann Nutr Metab (2002) 1.16

The role of the intestinal microflora for the development of the immune system in early childhood. Eur J Nutr (2002) 1.11

Microarray analysis reveals marked intestinal microbiota aberrancy in infants having eczema compared to healthy children in at-risk for atopic disease. BMC Microbiol (2013) 1.10

Semi-automated extraction of microbial DNA from feces for qPCR and phylogenetic microarray analysis. J Microbiol Methods (2010) 1.10

Microbial-gut interactions in health and disease. Probiotics. Best Pract Res Clin Gastroenterol (2004) 1.10

Presence of specific antibiotic (tet) resistance genes in infant faecal microbiota. FEMS Immunol Med Microbiol (2006) 1.09

Duodenal microbiota composition and mucosal homeostasis in pediatric celiac disease. BMC Gastroenterol (2013) 1.09

Maternal weight and excessive weight gain during pregnancy modify the immunomodulatory potential of breast milk. Pediatr Res (2012) 1.08

Stimulation of the secretion of pro-inflammatory cytokines by Bifidobacterium strains. Microbiol Immunol (2002) 1.07

Probiotics that modify disease risk. J Nutr (2005) 1.07

Binding rather than metabolism may explain the interaction of two food-Grade Lactobacillus strains with zearalenone and its derivative (')alpha-earalenol. Appl Environ Microbiol (2002) 1.07

Compositional development of Bifidobacterium and Lactobacillus microbiota is linked with crying and fussing in early infancy. PLoS One (2012) 1.06